Application of fucoidan sulfate in preparation of drug for preventing and treating chronic obstructive pulmonary disease (COPD)

A chronic obstructive, fucoidan technology, applied in the direction of drug combination, respiratory diseases, etc., can solve problems such as the use of fucoidan sulfate, which has not been documented in the literature, achieve good preventive and therapeutic effects, enhance immune function, and have good safety Effect
CN102764266AInactive Publication Date: 2012-11-07吉林省辉南长龙生化药业股份有限公司
11 Cites 10 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
吉林省辉南长龙生化药业股份有限公司
Publication Date
2012-11-07
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a new application of fucoidan sulfate in preparation of drug for preventing and treating chronic obstructive pulmonary disease (COPD). The fucoidan sulfate has fucose content greater than 29% and sulfate group content greater than 30%; and is a polysaccharide sulfate extracted from Phaeophyta algae such as Zostera Marina L., Laminaria Japonica Aresch., Sargassum Phyllocystum, Surgassum Thunbergii, Sargassum Integerrimum, Sargassum Fusiforme (Harv.) Setchel, Sargassum naozhouense, Sargassum Muticum, Sargassum Pallidum, etc. Animal tests show that fucoidan sulfate has definite curative effects in preventing and treating COPD, and relieving development of COPD.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to a new use of fucoidan sulfate, that is, the use of fucoidan sulfate in the preparation of drugs for the prevention and treatment of chronic obstructive pulmonary disease. Background technique

[0002] In the prior art, chronic obstructive pulmonary disease is called chronic obstructive pulmonary disease (COPD) for short, and it includes diseases such as chronic bronchitis (old chronic bronchitis) and emphysema. Its pathological feature is chronic obstruction of pulmonary airflow, which affects normal breathing and eventually leads to respiratory failure. Common symptoms are: recurrent coughing; wheezing, inability to breathe normally and panting. At present, there are about 40 million COPD patients in China, and 5 people die of COPD every minute, so it is called a quiet "killer". COPD is primarily caused by noxious particles or gases (most commonly from smoking) that trigger an abnormal inflammatory response in the lu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More